Korean J Med > Volume 78(2); 2010 > Article
The Korean Journal of Medicine 2010;78(2):226-230.
Autoimmune hemolytic anemia during PEG-interferon and ribavirin treatment for hepatitis C
Ji Youn Yu, Chang Wook Kim, Jin Dong Kim, Jeong Hyun Kwon, Jeong Won Jang, Seung Kew Yoon, Chang Don Lee
C형 간염의 페그-인터페론과 리바비린 치료 중 생긴 면역 용혈성 빈혈 1예
유지연, 김창욱, 김진동, 권정현, 장정원, 윤승규, 이창돈
Abstract
The current best treatment for HCV infection is combination therapy with PEG-interferon and ribavirin. This combination therapy has markedly increased the number of sustained virologic responders but is associated with various side effects, especially hematological abnormalities. We recently experienced a 45-year-old man who developed PEG-interferon induced autoimmune hemolytic anemia (AIHA) and retinal premacular hemorrhage. The worsening hemolysis after ribavirin withdrawal and exclusion of other causes implicated PEG-interferon as the cause of the AIHA. To the best of our knowledge, this is the first case reported from Korea. Treatment with PEG-interferon requires careful follow-up, as it can induce or exacerbate autoimmune diseases. (Korean J Med 78:226-230, 2010)
Key Words: Chronic hepatitis C; Autoimmune hemolytic anemia; Retinal hemorrhage; PEG-interferon


TOOLS
METRICS Graph View
  • 1,475 View
  • 10 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next